Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Introduction to R01:11

Introduction to R

5.0K
R is a powerful software environment for statistical computing and graphics. Originating as an implementation of the S language, developed at Bell Laboratories, R has evolved into a robust, open-source statistical software favored by statisticians and data scientists worldwide. Its comprehensive suite includes data manipulation, calculation, and graphical display capabilities, making it versatile for data analysis and visualization. Its programming language is at the core of R's...
5.0K
Introduction to force01:25

Introduction to force

1.2K
Consider water flowing from a nozzle to a turbine vane. As the water hits the turbine vane, it exerts a force that causes it to move along the flow of direction. Force is an impact that changes an object's motion, shape, or orientation. Forces can be caused by physical contact, such as a push or pull, or through non-contact interactions, such as magnetic or gravitational forces. Force is a vector quantity with both magnitude and direction, and is measured in newtons (N) in the SI unit...
1.2K
Introduction to Urinary System01:13

Introduction to Urinary System

9.2K
The urinary system consists of two kidneys, two ureters, the urinary bladder, and the urethra.
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
9.2K
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

2.2K
Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
2.2K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

908
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
908
Appendicitis-I: Introduction01:22

Appendicitis-I: Introduction

2.5K
The appendix, a small, narrow, blind tube extending from the inferior part of the cecum, is widely regarded as a vestigial organ, having lost much of its original function through evolution. Despite its diminished role, the appendix can become inflamed, a condition known as appendicitis.
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
2.5K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Prospective Validation of the New PLS Diagnostic Criteria From PLS Natural History Study: EMG and Neurofilament Analyses.

Muscle & nerve·2026
Same author

Study 19 (MCI186-19) Post Hoc Analyses.

Muscle & nerve·2026
Same author

Safety of Intravenous Edaravone in Clinical Practice.

Muscle & nerve·2026
Same author

Generalizability of Edaravone Efficacy.

Muscle & nerve·2026
Same author

Current and Ongoing Clinical Studies.

Muscle & nerve·2026
Same author

Phase 3b Extension Study MT-1186-A04 to Evaluate the Continued Efficacy and Safety of Edaravone Oral Suspension for Up to an Additional 48 Weeks in Patients With Amyotrophic Lateral Sclerosis.

Muscle & nerve·2025
Same journal

The Use of the Four Square Step Test and the 10-m Walk/Run Test to Determine Fall Risk in Children With Duchenne Muscular Dystrophy.

Muscle & nerve·2026
Same journal

Administration of Schwann Cell-Like Cells Differentiated From Tonsil-Derived Mesenchymal Stem Cells Promotes Peripheral Nerve Regeneration by Inducing Macrophage Polarization in a Chronic Constriction Injury Model.

Muscle & nerve·2026
Same journal

Muscle Ultrasound Is a Sensitive Outcome Measure in ALS.

Muscle & nerve·2026
Same journal

The Impact of Sponsored Genetic Testing in 170 Consecutive Consenting Patients With Amyotrophic Lateral Sclerosis: A Single-Site Retrospective Review.

Muscle & nerve·2026
Same journal

Determinants of the Maximal Nerve Cross-Sectional Area and Its Role in the Separation of Entrapment and Compression Ulnar Neuropathies at the Elbow.

Muscle & nerve·2026
Same journal

Myasthenia Gravis and Thymoma.

Muscle & nerve·2026
関連記事をすべて見る

関連する実験動画

Updated: Feb 8, 2026

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans
09:38

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans

Published on: November 29, 2013

17.6K

補遺の紹介

Kelly G Gwathmey1, Stephen Apple2

  • 1Department of Neurology, Virginia Commonwealth University, Richmond, Virginia, USA.

Muscle & nerve
|February 7, 2026
PubMed
まとめ
この要約は機械生成です。

ALS治療薬であるエダラボンは、新しい経口懸濁液製剤を提供します。これは、静脈注射剤の確立された利点を基盤として、ALS患者の治療選択肢を拡大するものです。

キーワード:
スタディ19筋萎縮性側索硬化症エダラボン有効性安全性

さらに関連する動画

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.9K
Therapeutic Effectiveness of a Dietary Supplement for Management of Halitosis in Dogs
07:33

Therapeutic Effectiveness of a Dietary Supplement for Management of Halitosis in Dogs

Published on: July 6, 2015

12.0K

関連する実験動画

Last Updated: Feb 8, 2026

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans
09:38

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans

Published on: November 29, 2013

17.6K
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.9K
Therapeutic Effectiveness of a Dietary Supplement for Management of Halitosis in Dogs
07:33

Therapeutic Effectiveness of a Dietary Supplement for Management of Halitosis in Dogs

Published on: July 6, 2015

12.0K

科学分野:

  • 神経学
  • 薬理学
  • 臨床研究

背景:

  • 筋萎縮性側索硬化症（ALS）は、多様な患者の病状を呈する進行性の神経筋疾患です。
  • 現在FDA承認済みのALS治療薬には、リルゾール、エダラボン（IVおよび経口）、およびトフィルセンが含まれます。
  • エダラボンの有効性は、当初日本の患者（スタディ19）で示され、静脈注射剤の承認につながりました。

研究 の 目的:

  • より広範なALS患者集団におけるエダラボン使用の理解を深めるためのデータを提示すること。
  • エダラボンの安全性、有効性の一般化可能性、臨床転帰、および医療経済を調査すること。
  • ALS管理におけるエダラボンに関する進化するエビデンスについて、臨床医、研究者、および関係者に情報を提供すること。

主な方法:

  • 臨床試験、事後解析、および臨床研究からのデータのレビュー。
  • 臨床 practice における安全性と有効性の一般化可能性に焦点を当てる。
  • 医療経済およびアウトカムリサーチの組み込み。

主要な成果:

  • エダラボン経口懸濁液は、静脈注射剤のエダラボンと一貫した安全性プロファイルを持ち、良好な忍容性を示しました。
  • 本補遺は、ALSにおけるエダラボン使用の証拠基盤を拡大するデータを示しています。
  • 結果は、安全性、有効性、臨床転帰、および医療経済をカバーしています。

結論:

  • 静脈注射剤および経口剤の両方の形態のエダラボンは、ALSにとって重要な治療選択肢です。
  • さらなる研究とデータ分析により、ALSにおけるエダラボンの役割の理解が引き続き洗練されています。
  • 提示されたデータは、ALS患者管理のための情報に基づいた意思決定を支持します。